Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurotherapeutics
Metadata
Title
Biomarkers of Alzheimer disease in plasma
Author
Michael C. Irizarry
Publication date
01-04-2004
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 2/2004
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1602/neurorx.1.2.226

Other articles of this Issue 2/2004

Neurotherapeutics 2/2004 Go to the issue

OriginalPaper

Molecular neuroimaging in Alzheimer’s disease

OriginalPaper

Genetics of Parkinson disease

OriginalPaper

Quantitative magnetic resonance techniques as surrogate markers of Alzheimer’s disease

OriginalPaper

Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington’s disease

OriginalPaper

Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis

OriginalPaper

Measures and markers in Amyotrophic Lateral Sclerosis